olopatadine hydrochloride (Perrigo New York Inc)
Welcome to the PulseAid listing for the olopatadine hydrochloride drug offered from Perrigo New York Inc. This Decreased Histamine Release [PE],Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Perrigo New York Inc |
| NON-PROPRIETARY NAME: | Olopatadine Hydrochloride |
| SUBSTANCE NAME: | OLOPATADINE HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Decreased Histamine Release [PE],Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Inhibitor [EPC] |
| ROUTE: | NASAL |
| DOSAGE FORM: | SPRAY |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-06-14 |
| END MARKETING DATE: | 0000-00-00 |
olopatadine hydrochloride HUMAN PRESCRIPTION DRUG Details:
| Item Description | olopatadine hydrochloride from Perrigo New York Inc |
| LABELER NAME: | Perrigo New York Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 665(ug/1) |
| START MARKETING DATE: | 2017-06-14 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 45802-104_8c5cba2a-2fc0-4208-b940-fb288ff9809b |
| PRODUCT NDC: | 45802-104 |
| APPLICATION NUMBER: | ANDA202853 |
Other OLOPATADINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
